Sarah Galang has significant experience in clinical operations, starting as a Clinical Research Associate and Clinical Trial Coordinator at PPD from July 2020 to April 2022, where involvement included providing unique novel rare disease therapies with orphan drug designation for Hypereosinophilic Syndrome and supporting managed access programs. Currently serving as a Senior Clinical Research Associate at PPD since April 2022, Sarah has built upon a strong educational background with a B.S. in Genetics and Developmental Biology, Health Policy and Administration from Penn State University, along with honors from the Schreyer Honors College.
This person is not in the org chart
This person is not in any teams
This person is not in any offices